BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35285410)

  • 1. KLF2-induced circZKSCAN1 potentiates the tumorigenic properties of clear cell renal cell carcinoma by targeting the miR-1294/PIM1 axis.
    Li M; Zhang M; Chen M; Xiao J; Mu X; Peng J; Fan J
    Cell Cycle; 2022 Jul; 21(13):1376-1390. PubMed ID: 35285410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis.
    Zhao B; Liu L; Mao J; Zhang Z; Wang Q; Li Q
    Cell Death Dis; 2018 Feb; 9(3):307. PubMed ID: 29472550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZKSCAN1 gene and its related circular RNA (circZKSCAN1) both inhibit hepatocellular carcinoma cell growth, migration, and invasion but through different signaling pathways.
    Yao Z; Luo J; Hu K; Lin J; Huang H; Wang Q; Zhang P; Xiong Z; He C; Huang Z; Liu B; Yang Y
    Mol Oncol; 2017 Apr; 11(4):422-437. PubMed ID: 28211215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. circFOXO3 Induced by KLF16 Modulates Clear Cell Renal Cell Carcinoma Growth and Natural Killer Cell Cytotoxic Activity through Sponging miR-29a-3p and miR-122-5p.
    Yang F; Chen Y; Luo L; Nong S; Li T
    Dis Markers; 2022; 2022():6062236. PubMed ID: 36072902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma.
    Lu Y; Qin H; Jiang B; Lu W; Hao J; Cao W; Du L; Chen W; Zhao X; Guo H
    Cancer Lett; 2021 Dec; 522():1-13. PubMed ID: 34520818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T.
    Wu Y; Zhang C; Peng D; He S; Huang C; Qian J; Zhu W; Feng N; Gong Y; Li X; Zhou L
    Hum Cell; 2022 Mar; 35(2):542-556. PubMed ID: 35129808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-155-5p Promotes Cell Proliferation and Migration of Clear Cell Renal Cell Carcinoma by Targeting PEG3.
    Wu H; Wu H; Sun P; Zhu D; Ma M; Fan W
    Urol Int; 2021; 105(9-10):906-915. PubMed ID: 34192708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RP11-367G18.1 V2 enhances clear cell renal cell carcinoma progression via induction of epithelial-mesenchymal transition.
    Shao IH; Peng PH; Wu HH; Chen JL; Lai JC; Chang JS; Wu HT; Wu KJ; Pang ST; Hsu KW
    Cancer Med; 2023 Apr; 12(8):9788-9801. PubMed ID: 36847128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircPCNXL2 sponges miR-153 to promote the proliferation and invasion of renal cancer cells through upregulating ZEB2.
    Zhou B; Zheng P; Li Z; Li H; Wang X; Shi Z; Han Q
    Cell Cycle; 2018; 17(23):2644-2654. PubMed ID: 30488762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A lncRNA TCL6-miR-155 Interaction Regulates the Src-Akt-EMT Network to Mediate Kidney Cancer Progression and Metastasis.
    Kulkarni P; Dasgupta P; Hashimoto Y; Shiina M; Shahryari V; Tabatabai ZL; Yamamura S; Tanaka Y; Saini S; Dahiya R; Majid S
    Cancer Res; 2021 Mar; 81(6):1500-1512. PubMed ID: 33500248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive profiling of circRNAs and the tumor suppressor function of circHIPK3 in clear cell renal carcinoma.
    Li H; Heng B; Ouyang P; Xie X; Zhang T; Chen G; Chen Z; Cheang K; Lai C
    J Mol Histol; 2020 Jun; 51(3):317-327. PubMed ID: 32409849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
    Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X
    Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircZKSCAN1 Suppresses Hepatocellular Carcinoma Tumorigenesis by Regulating miR-873-5p/Downregulation of Deleted in Liver Cancer 1.
    Li J; Bao S; Wang L; Wang R
    Dig Dis Sci; 2021 Dec; 66(12):4374-4383. PubMed ID: 33439397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis.
    Liu H; Hu G; Wang Z; Liu Q; Zhang J; Chen Y; Huang Y; Xue W; Xu Y; Zhai W
    Theranostics; 2020; 10(23):10791-10807. PubMed ID: 32929380
    [No Abstract]   [Full Text] [Related]  

  • 15. Hsa_circ_0085576 promotes clear cell renal cell carcinoma tumorigenesis and metastasis through the miR-498/YAP1 axis.
    Liu G; Zhou J; Piao Y; Zhao X; Zuo Y; Ji Z
    Aging (Albany NY); 2020 Jun; 12(12):11530-11549. PubMed ID: 32541093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of circATG9A as a novel biomarker for renal cell carcinoma.
    Shen Y; Wu R; Zhuo Z; Deng X; Li W; Liu C
    Cancer Gene Ther; 2024 Jan; 31(1):82-93. PubMed ID: 37945969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of TUG1 by shRNA inhibited renal cell carcinoma formation by miR-299-3p/VEGF axis in vitro and in vivo.
    Li Y; Zheng D; Pan L; Dai Y; Cai S; Zhao L; Zhu H
    Eur J Pharmacol; 2019 Oct; 860():172536. PubMed ID: 31310753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGA1-mediated miR-671-5p targets APC to promote metastasis of clear cell renal cell carcinoma through Wnt signaling.
    Chi XG; Meng XX; Ding DL; Xuan XH; Chen YZ; Cai Q; Wang A
    Neoplasma; 2020 Jan; 67(1):46-53. PubMed ID: 31686521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal microRNA-15a from ACHN cells aggravates clear cell renal cell carcinoma via the BTG2/PI3K/AKT axis.
    Li DY; Lin FF; Li GP; Zeng FC
    Kaohsiung J Med Sci; 2021 Nov; 37(11):973-982. PubMed ID: 34337864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. circCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p/EIF4EBP1 axis.
    Gui CP; Liao B; Luo CG; Chen YH; Tan L; Tang YM; Li JY; Hou Y; Song HD; Lin HS; Xu QH; Yao GS; Yao HH; Xi-Liu ; Luo JH; Cao JZ; Wei JH
    Mol Cancer; 2021 Dec; 20(1):169. PubMed ID: 34922539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.